Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice

Circulation

Volumn 112, Issue 9 SUPPL., 2005, Pages

  Ali, Ziad A ^a,b   Bursill, Christina A ^a,b   Hu, Yanhua ^c   Choudhury, Robin P ^a   Xu, Qingbo ^c   Greaves, David R ^b   Channon, Keith M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Gene therapy; Inflammation; Surgery; Veins

Indexed keywords

ADENOVIRUS VECTOR; ALPHA ACTIN; APOLIPOPROTEIN E; BETA CHEMOKINE; BETA CHEMOKINE BINDING PROTEIN; BINDING PROTEIN; CHEMOKINE RECEPTOR ANTAGONIST; GREEN FLUORESCENT PROTEIN; PROTEIN 35K; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; BLOOD VESSEL WALL THICKNESS; CAVA VEIN; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; GENE TRANSFER; GRAFT FAILURE; GRAFT PATENCY; KNOCKOUT MOUSE; MACROPHAGE MIGRATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THICKNESS; VEIN GRAFT; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD VESSEL PROSTHESIS; CAROTID ARTERY, COMMON; CELL DIVISION; CELL MOVEMENT; CHEMOKINES, CC; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GRAFT OCCLUSION, VASCULAR; GREEN FLUORESCENT PROTEINS; HYPERCHOLESTEROLEMIA; INJECTIONS, INTRAVENOUS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECOMBINANT FUSION PROTEINS; RECURRENCE; TRANSDUCTION, GENETIC; VACCINIA VIRUS; VENA CAVA, INFERIOR; VIRAL PROTEINS;

EID: 24644514305     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.526129     Document Type: Article

References (25)

1. Motwani JG, Topol EJ. Aortocotonary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97:916-931.
2. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990;15:1667-1687.
3. Weber C, Schober A, Zernecke A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol. 2004;24:1997-2008.
4. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394:894-897.
5. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest. 1999;103:773-778.
6. Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res. 2004;94:253-261
7. Egashira K, Zhao Q, Kataoka C, Ohtani K, Usui M, Charo IF, Nishida K, Inoue S, Katoh M, Ichiki T, Takeshita A. Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res. 2002;90:1167-1172.
8. Usui M, Egashira K, Ohtani K, Kataoka C, Ishibashi M, Hiasa K, Katoh M, Zhao Q, Kitamoto S, Takeshita A. Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys. FASEB J. 2002;16:1838-1840.
9. Ohtani K, Usui M, Nakano K, Kohjimoto Y, Kitajima S, Hirouchi Y, Li XH, Kitamoto S, Takeshita A, Egashira K. Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys. Gene Ther. 2004;11:1273-1282.
10. Stark VK, Hoch JR, Warner TF, Hullett DA. Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia. Arterioscler Thromb Vasc Biol. 1997;17:1614-1621.
11. Alcami A, Symons JA, Collins PD, Williams TJ, Smith GL. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol. 1998;160:624-633.
12. Bursill CA, Choudhury RP, Ali Z, Greaves DR, Channon KM. Broadspectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice Circulation. 2004;110:2460-2466.
13. Bursill C, Cai S, Channon KM, Greaves DR. Adenoviral-mediated delivery of a viral chemokine binding protein blocks CC-chemokine activity in vitro and in vivo. Immunobiology. 2003;207:1-10.
14. Mayr M, Li C, Zou Y, Huemer U, Hu Y, Xu Q. Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J. 2000;14:261-270.
15. Dietrich H, Hu Y, Zou Y, Huemer U, Metzler B, Li C, Mayr M, Xu Q. Rapid development of vein graft atheroma in ApoE-deficient mice. Am J Pathol. 2000;157:659-669.
16. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996;94:1655-1664.
17. Shimizu K, Sugiyama S, Aikawa M, Fukumoto Y, Rabkin E, Libby P, Mitchell RN. Host bone-marrow cells are a source of donor intimal smooth muscle like cells in murine aortic transplant arteriopathy. Nat Med. 2001;7:738-741.
18. Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, Xu Q. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest. 2004;113:1258-1265.
19. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002;8:403-409.
20. Gautam SC, Pindolia KR, Noth CJ, Janakiraman N, Xu YX, Chapman RA. Chemokine gene expression in bone marrow stromal cells: down-regulation with sodium salicylate. Blood. 1995;86:2541-2550.
21. Xu YX, Talati BR, Janakiraman N, Chapman RA, Gautam SC. Growth factors: production of monocyte chemotactic protein-1 (MCP-1/JE) by bone marrow stromal cells: effect on the migration and proliferation of hematopoietic progenitor cells. Hematology. 1999;4:345-356.
22. Schecter AD, Berman AB, Taubman MB. Chemokine receptors in vascular smooth muscle. Microcirculation. 2003;10:265-272.
23. Haque NS, Fallon JT, Pan JJ, Taubman MB, Harpel PC. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion. Blood. 2004;103:1296-1304.
24. Zou Y, Hu Y, Mayr M, Dietrich H, Wick G, Xu Q. Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice. Circ Res. 2000;86:434-440.
25. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A. 1994;91:4407-4411.